SUNRx Webinar: Manufacturer Mandates and 340B ESP™ — A Panel Discussion

Pacific Time
November 10, 2022 | 12:00 - 1:00PM PST

HASC members are cordially invited to a webinar with SUNRx, a HASC Endorsed Business Partner, on how your organization can benefit from an efficient and compliant 340B claims capture program. Speakers will be Aaron Lott, President, AuthorityRx; Donna Petty, Managing Principal, Account Management, SUNRx; and John Bretz, Director, Strategic Relations, SUNRx.

The current environment created by various drug companies has substantially disrupted administration of the 340B drug pricing program. This impact, in turn, has created financial shortfalls for entities nationwide. While 340B ESP aims to bring together pharmaceutical manufacturers and 340B covered organizations to improve program transparency, challenges have arisen that are causing major issues.

Entities that are aware of these challenges can realize additional savings by optimizing their 340B claims capture program compliance. Our panelists will provide background and insights on how your organization can effectively engage with 340B ESP:

  • Historical review: How regulatory affairs have arrived at their current state
  • Current regulatory environment: An overview of activity
  • Implications moving forward: What your entity should consider for the future

SUNRx is a 340B administrator that helps hospitals, Federally Qualified Health Centers and other covered entities maximize their 340B program compliance, enabling them to expand access to affordable medications for low-income and uninsured patients. The company provides comprehensive 340B services for disproportionate share hospitals, sole community, critical access and children’s hospitals. To learn more, visit SUNRx’s website.

Please RSVP at your earliest convenience for the webinar. We look forward to seeing you online.